Growth momentum MDPen is expanding its market presence with recent launch of Corrective Microneedling and a new client win (Lifecodeatl), indicating momentum in product adoption and enterprise customer acquisition that sales teams can leverage to pursue similar partnerships and clinics.

Clinical relevance The technology targets skin rejuvenation, wrinkle reduction, and scar treatment, aligning with high-demand aesthetic procedures. This presents cross-sell opportunities to dermatology clinics, medspas, and cosmetic surgeons seeking advanced microneedling solutions.

Digital reach Multiple tech platforms (Shopify, WordPress, HubSpot, Google Workspace) suggest a strong digital commerce and inbound marketing footprint. Sales teams can engage by offering bundled digital marketing and training support to clinics adopting the product.

Financial potential Reported revenue range of one to ten million indicates a scalable operation with room for growth through channel partnerships, strategic accounts, and expanded distribution in complementary markets and geographies.

Competitive positioning With peers at various scale in the space, MDPen’s focus on corrective microneedling and ongoing product launches signals ongoing differentiation. Target high-value providers seeking cutting-edge microneedling technology and ongoing innovation.